Dr. Gabriel Axelrud serves as the Medical Director of Radiation Oncology and Chair of the Cancer Committee at Covenant Health’s Joe Arrington Cancer Research & Treatment Center, located in Lubbock, Texas. Covenant Health is a member of Providence St. Joseph Health, a major not-for-profit health system in the United States. Dr. Axelrud is based in the United States, currently affiliated with Covenant Health and Covenant Children's Hospital, and holds a Board Certification in Radiation Oncology.
He earned his medical degree from the Texas A&M Health Science Center College of Medicine and has over a decade of experience in clinical radiation oncology practice. Dr. Axelrud is active in oncology leadership, evidenced by his medical directorship role and chairmanship of the institutional Cancer Committee at Covenant Health, highlighting his influence on strategic oncology care delivery and quality standards within the organization.
Dr. Axelrud is recognized for contributing to cutting-edge advances in radiation oncology, presenting these advances in professional forums, and engaging in community-focused educational efforts, such as podcasts on cancer prevention and social media outreach. His commitment to patient care is illustrated by his emphasis on building meaningful relationships with cancer patients and leading a multidisciplinary team through treatment services.
He has played a key role in securing Accreditation Program for Excellence (APEx) accreditation for Radiation Oncology services at Covenant Health, confirming his leadership in ensuring safety, quality, and adherence to national radiation oncology standards. Public communications note his involvement in elevating the institution’s protocols and standards to meet ASTRO (American Society for Radiation Oncology) certification criteria.
Dr. Axelrud’s professional profile is supported by:
- Multiple affiliations within the Lubbock, TX region, including Covenant Children’s Hospital and Nor-Lea Hospital District.
- Active participation in national and regional oncology societies, with documented engagement at ASTRO annual meetings and association with research and continuing medical education activities.
- A research footprint of at least 10 published works focused on Intensity Modulated Radiation Therapy (IMRT) and dose escalation techniques, with approximately 36 citations, indicating an ongoing contribution to evidence-based radiation oncology science.
- Leadership roles within oversight committees on survivorship care, confirming involvement in broad oncology program governance.
- Numerous presentations at medical conferences and educational symposia, evidencing peer recognition and expertise dissemination.
His clinical focus covers multimodal radiation therapy protocols, management of head and neck cancer, breast cancer multidisciplinary treatment, and implementation of advanced radiation techniques tailored to improve patient quality of life and treatment outcomes.
Dr. Axelrud is reachable at Covenant Health’s Lubbock office at 4101 22nd Place, Lubbock, TX 79410, with contact number (806) 725-8000. His professional online presence includes a LinkedIn profile (http://www.linkedin.com/in/axelrud) and an active Instagram account (@axelrudmd), where he shares clinical insights and community engagement related to oncology care.
This profile underscores Dr. Axelrud’s position as a pivotal medical leader within Covenant Health’s oncology services, with both clinical expertise and administrative authority underpinning the delivery and evolution of radiation oncology programs. His affiliation with Providence St. Joseph Health and ability to champion accreditation initiatives position him as a key influencer in oncology care strategy and innovation at the regional health system level.
